• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯尼达明的糖基和多元醇前药。

Glycosyl and polyalcoholic prodrugs of lonidamine.

作者信息

Giorgioni G, Ruggieri S, Di Stefano A, Sozio P, Cinque B, Di Marzio L, Santoni G, Claudi F

机构信息

Dipartimento di Scienze Chimiche, Università di Camerino, Via S. Agostino 1, 62032 Camerino (MC), Italy.

出版信息

Bioorg Med Chem Lett. 2008 Apr 1;18(7):2445-50. doi: 10.1016/j.bmcl.2008.02.046. Epub 2008 Mar 5.

DOI:10.1016/j.bmcl.2008.02.046
PMID:18321702
Abstract

Polyhydric alcohol derivatives of the anticancer agent lonidamine (LND) have been synthesized. The increased water solubility showed by prodrugs 4, 7, and 25 together with their logP values (2.19, 2.55, and 2.54, respectively) and chemical stability might be beneficial for prodrugs absorption after oral administration. Moreover, the new prodrugs undergo enzymatic hydrolysis in plasma and release LND demonstrating that they are promising candidates for in vivo investigations.

摘要

已合成抗癌药氯尼达明(LND)的多元醇衍生物。前药4、7和25表现出的水溶性增加以及它们的logP值(分别为2.19、2.55和2.54)和化学稳定性可能有利于口服给药后前药的吸收。此外,新的前药在血浆中进行酶促水解并释放LND,表明它们是体内研究的有前途的候选物。

相似文献

1
Glycosyl and polyalcoholic prodrugs of lonidamine.氯尼达明的糖基和多元醇前药。
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2445-50. doi: 10.1016/j.bmcl.2008.02.046. Epub 2008 Mar 5.
2
Prodrugs of hydroxymethylpentamethylmelamine: a principal active metabolite of the antineoplastic agent hexamethylmelamine.羟甲基五甲基三聚氰胺的前药:抗肿瘤药六甲蜜胺的主要活性代谢物。
Drug Des Discov. 1994 Feb;11(2):135-47.
3
Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine.卡马西平新型水溶性亚磺酰胺前药的制备、表征及体内转化
Bioorg Med Chem Lett. 2007 Dec 1;17(23):6629-32. doi: 10.1016/j.bmcl.2007.09.045. Epub 2007 Sep 15.
4
Synthesis, characterization, and preliminary in vivo tests of new poly(ethylene glycol) conjugates of the antitumor agent 10-amino-7-ethylcamptothecin.新型抗肿瘤药物10-氨基-7-乙基喜树碱聚乙二醇缀合物的合成、表征及初步体内试验
J Med Chem. 2004 Feb 26;47(5):1280-9. doi: 10.1021/jm031072e.
5
Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.氨基-康普他汀氨基酸前药的合成及其抗肿瘤活性
Anticancer Drug Des. 1999 Dec;14(6):539-48.
6
No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.紫杉烷类水溶性前药的无辅助、无副产物策略:O-N分子内酰基和酰氧基迁移反应的范围和局限性
J Med Chem. 2005 Apr 7;48(7):2655-66. doi: 10.1021/jm049344g.
7
Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.硫氧还蛋白-硫氧还蛋白还原酶系统前药抑制剂的合成及生物活性
Org Biomol Chem. 2005 Nov 7;3(21):3880-2. doi: 10.1039/b510718k. Epub 2005 Sep 28.
8
Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.氟芬那酸和双氯芬酸的氨基甲酰氧基甲酯前药:抑制在水性介质中的重排途径。
Arch Pharm (Weinheim). 2007 Jan;340(1):32-40. doi: 10.1002/ardp.200600145.
9
In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs.槲皮素-3-O-酰基酯作为局部用前药的体外评价
Int J Pharm. 2007 May 24;336(2):257-62. doi: 10.1016/j.ijpharm.2006.12.003. Epub 2006 Dec 6.
10
Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.2-甲氧基雌二醇3-磷酸酯、17-磷酸酯和3,17-二磷酸酯的合成及体内抗肿瘤评价
J Med Chem. 2007 Dec 27;50(26):6700-5. doi: 10.1021/jm070639e. Epub 2007 Dec 6.

引用本文的文献

1
Design, Synthesis, and Biological Evaluation of Naphthoquinone Salts as Anticancer Agents.萘醌盐作为抗癌剂的设计、合成及生物学评价
Molecules. 2025 Apr 27;30(9):1938. doi: 10.3390/molecules30091938.
2
Supramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble Drugs.用于提高难溶性药物生物利用度的碳水化合物超分子络合作用
Molecules. 2015 Oct 27;20(10):19620-46. doi: 10.3390/molecules201019620.
3
Anticancer agents that counteract tumor glycolysis.抗癌药物,可抑制肿瘤糖酵解。
ChemMedChem. 2012 Aug;7(8):1318-50. doi: 10.1002/cmdc.201200176. Epub 2012 Jun 8.
4
Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.多模态策略克服肿瘤药物耐药性:缺氧、瓦博格效应、干细胞和多功能纳米技术。
J Control Release. 2011 Oct 30;155(2):237-47. doi: 10.1016/j.jconrel.2011.03.032. Epub 2011 Apr 8.
5
Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.用于联合紫杉醇/洛尼定给药以治疗人乳腺癌和卵巢肿瘤细胞多药耐药的 EGFR 靶向聚合物共混纳米载体的研制。
Mol Pharm. 2011 Feb 7;8(1):185-203. doi: 10.1021/mp1002653. Epub 2010 Nov 24.